Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page shows a minor update to the Study Record Dates with a new Last Update Posted timestamp; core study content such as design, eligibility, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedUpdated location and date/status fields: replaced San Marcos, TX details with San Marcos, CA details and newer timestamps; older entries removed.SummaryDifference0.4%

- Check37 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference0.5%

- Check44 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.0%

- Check58 days agoChange DetectedRelease updated to v3.0.2 (replacing v3.0.1); 'Back to Top' link removed.SummaryDifference0.0%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.0%

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.